DCGI launches nationwide drive to curb illegal sale of GLP-1 drugs
In a significant move to uphold ethical pharma practices and safeguard public health, the Drugs Controller General of India has…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
Building India Pharma Inc’s innovation muscle
While we agree that “what got us here (an affordable generics powerhouse) will not get us there (a leader in pharma innovation)”,…
A biosimilar boost amid trade barriers
Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…
GDHS 2025: DCGI emphasises on balancing innovation with public safety
At Global Digital Health Summit (GDHS) 2025, Dr. Rajeev Raghuvanshi, Drugs Controller General of India (DCGI) emphasised on the…
DCGI allows stickering of revised MRP on medical devices post GST reform
The drug regulator has permitted the temporary affixing of stickers to reflect revised Maximum Retail Prices (MRPs) on certain…
Akums’ gains patent for Tablet-in-Tablet technology for NVP medication
The outer layer provides rapid relief from nausea, while the inner core maintains a prolonged action
CDSCO launches online registration process for CROs
As per the Health Ministry, registration of CROs will become mandatory with effect from April 1, 2025
CDSCO cracks down on export licenses, antibiotic approvals
Can online courses and training programmes guarantee more effective regulation and better quality medicines?
Orchid Pharma receives DCGI approval for its antibiotic drug combination of Cefepime and…
Its reportedly company’s first invented and made-in-India drug
Orchid Pharma, has received Drugs Controller General of India…
Akums introduces DCGI approved FDC medication
Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets for treatment of resistant Hypertension